Alpine Immune Sciences Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
All right. Good afternoon, everyone. Thanks for joining us here at the SVB Securities Global Biopharma Conference. My name is Tom Smith. I'm one of the senior biotech analysts here at SVB and excited to welcome our next presenting company, Alpine Immune Sciences, and very happy to introduce Chief Business Officer. Remy Durand. Remy, thanks for joining us.
Great. Thank you, Tom and SVB for the invitation to present here at the conference this year. And thank you to everyone listening in on the webcast. As Tom mentioned, my name is Remy Durand. And I lead investor relations, business development, and corporate strategy for Alpine Immune Sciences. Today, I'll be making forward-looking statements. Please consult our website for a full list of SEC filings.
At Alpine, we're leading the next evolution of immunotherapies for autoimmune disease and inflammatory disease with two compelling molecules, both developed from our highly productive directed
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |